https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-receives-11m-grant-from-national-institute-on-drug-abuse-for-the-clinical-development-of-emb-001-for-the-treatment-of-cocaine-addiction/2017-04-06T18:54:33+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-announces-successful-completion-of-phase-1-clinical-trial-testing-emb-001-a-potential-novel-treatment-for-addictions/2017-04-06T18:48:57+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-initiates-phase-1-clinical-trial-to-test-emb-001-as-a-novel-treatment-for-addictions/2017-04-06T18:59:01+00:00https://stagecpanel.emberaneuro.com/embera-ceo-provides-update-on-addiction-treatment/2016-09-16T15:10:39+00:00https://stagecpanel.emberaneuro.com/embera-technation-smoking-cessation/2016-12-05T20:03:23+00:00https://stagecpanel.emberaneuro.com/embera-compound-takes-new-addiction-treatment-tack/2016-09-14T20:25:37+00:00https://stagecpanel.emberaneuro.com/medicines-to-keep-addiction-away/2016-11-16T22:37:25+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-secures-a-2-financing-to-advance-emb-001-for-addictions-through-phase-1-clinical-trial/2017-04-06T19:02:49+00:00https://stagecpanel.emberaneuro.com/what-is-cocaine/2016-11-21T17:34:42+00:00https://stagecpanel.emberaneuro.com/letter-from-the-director-of-the-national-institute-on-drug-abuse/2016-11-21T17:23:45+00:00https://stagecpanel.emberaneuro.com/parents-educators/2016-11-21T17:27:45+00:00https://stagecpanel.emberaneuro.com/children-teens/2016-11-21T17:30:25+00:00https://stagecpanel.emberaneuro.com/patients-families/2016-11-21T17:33:15+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-receives-11m-grant-from-national-institute-on-drug-abuse-for-the-clinical-development-of-emb-001-for-the-treatment-of-cocaine-addiction-2/2016-12-15T19:25:29+00:00https://stagecpanel.emberaneuro.com/new-stress-response-modulation-drug-showing-promise-in-the-treatment-of-addiction/2017-01-04T20:51:07+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-announces-positive-topline-data-from-phase-1b-cocaine-interaction-study-of-emb-001/2017-05-08T16:57:52+00:00https://stagecpanel.emberaneuro.com/new-approach-to-drug-development-could-give-rise-to-cocaine-treatment/2017-06-13T14:23:33+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-to-present-at-the-2017-bio-investor-forum/2017-10-20T13:58:07+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-to-present-at-the-19th-annual-rodman-renshaw-global-investment-conference/2017-10-20T14:13:10+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-to-present-at-the-10th-annual-biotech-showcase/2017-12-12T15:20:13+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-chief-medical-officer-michael-detke-to-moderate-panel-on-opioid-abuse-at-bio-ceo-investor-conference/2018-02-13T19:38:39+00:00https://stagecpanel.emberaneuro.com/is-a-new-drug-crisis-looming/2018-02-20T22:23:16+00:00https://stagecpanel.emberaneuro.com/overshadowed-by-the-opioid-crisis-a-comeback-by-cocaine/2018-03-12T19:46:04+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-to-present-at-the-2018-bio-international-convention-in-boston/2018-06-04T15:34:38+00:00https://stagecpanel.emberaneuro.com/meet-embera-neurotherapeutics-ceo-bob-linke-and-chief-medical-officer-mike-detke/2018-08-02T21:44:12+00:00https://stagecpanel.emberaneuro.com/the-addiction-series/2018-08-16T19:46:42+00:00https://stagecpanel.emberaneuro.com/its-time-to-be-proactive-on-stimulant-use/2018-11-13T21:38:28+00:00https://stagecpanel.emberaneuro.com/embera-neurotherapeutics-completes-series-b-financing-and-receives-grants-to-advance-emb-001-into-phase-2-clinical-studies-in-cocaine-use-disorder-and-smoking-cessation/2022-10-17T16:50:25+00:00